JP2001508812A - 異性体濃縮共役リノール酸組成物 - Google Patents
異性体濃縮共役リノール酸組成物Info
- Publication number
- JP2001508812A JP2001508812A JP55536299A JP55536299A JP2001508812A JP 2001508812 A JP2001508812 A JP 2001508812A JP 55536299 A JP55536299 A JP 55536299A JP 55536299 A JP55536299 A JP 55536299A JP 2001508812 A JP2001508812 A JP 2001508812A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cla
- food
- acid
- linoleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title claims abstract description 46
- 229940108924 conjugated linoleic acid Drugs 0.000 title claims abstract description 34
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 24
- 241001465754 Metazoa Species 0.000 claims description 68
- 235000013305 food Nutrition 0.000 claims description 53
- 235000005911 diet Nutrition 0.000 claims description 34
- 230000037213 diet Effects 0.000 claims description 32
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 claims description 26
- 235000021588 free fatty acids Nutrition 0.000 claims description 16
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical class C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 16
- 125000005907 alkyl ester group Chemical group 0.000 claims description 15
- 150000002632 lipids Chemical class 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- 150000003626 triacylglycerols Chemical class 0.000 claims description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
- 239000006053 animal diet Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 2
- 230000001268 conjugating effect Effects 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 241000699670 Mus sp. Species 0.000 description 19
- 241000030538 Thecla Species 0.000 description 17
- JBYXPOFIGCOSSB-XBLVEGMJSA-N 9E,11E-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C\CCCCCCCC(O)=O JBYXPOFIGCOSSB-XBLVEGMJSA-N 0.000 description 16
- 239000003925 fat Substances 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 210000000577 adipose tissue Anatomy 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000020778 linoleic acid Nutrition 0.000 description 11
- 241000282887 Suidae Species 0.000 description 10
- 125000004494 ethyl ester group Chemical group 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000282412 Homo Species 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000020940 control diet Nutrition 0.000 description 9
- 238000006317 isomerization reaction Methods 0.000 description 9
- 230000004584 weight gain Effects 0.000 description 9
- 235000019786 weight gain Nutrition 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000004817 gas chromatography Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000004580 weight loss Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 4
- 244000020518 Carthamus tinctorius Species 0.000 description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 235000019485 Safflower oil Nutrition 0.000 description 4
- 235000019486 Sunflower oil Nutrition 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000005687 corn oil Nutrition 0.000 description 4
- 239000002285 corn oil Substances 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 235000005713 safflower oil Nutrition 0.000 description 4
- 239000003813 safflower oil Substances 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002600 sunflower oil Substances 0.000 description 4
- 102000003390 tumor necrosis factor Human genes 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- GKJZMAHZJGSBKD-UHFFFAOYSA-N (10E,12E)-Octadeca-9,11-dienoic acid Natural products CCCCCC=CC=CCCCCCCCCC(O)=O GKJZMAHZJGSBKD-UHFFFAOYSA-N 0.000 description 3
- GKJZMAHZJGSBKD-BLHCBFLLSA-N (10e,12e)-octadeca-10,12-dienoic acid Chemical compound CCCCC\C=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-BLHCBFLLSA-N 0.000 description 3
- GKJZMAHZJGSBKD-ANYPYVPJSA-N 10-trans-12-cis-linoleic acid Natural products CCCCCC=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-ANYPYVPJSA-N 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 231100001055 skeletal defect Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002702 enteric coating Substances 0.000 description 2
- 238000009505 enteric coating Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000006140 methanolysis reaction Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000009284 tracheal contraction Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- WHUHTCSYMDOIGU-FNORWQNLSA-N (3e)-octadeca-1,3-diene Chemical compound CCCCCCCCCCCCCC\C=C\C=C WHUHTCSYMDOIGU-FNORWQNLSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ADHNUPOJJCKWRT-UHFFFAOYSA-N 2,4-octadecadienoic acid Natural products CCCCCCCCCCCCCC=CC=CC(O)=O ADHNUPOJJCKWRT-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000700662 Fowlpox virus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003043 biohydrogenation Effects 0.000 description 1
- 230000010256 bone deposition Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000015223 cooked beef Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- JGFMXQLVWUGIPI-UHFFFAOYSA-N octadeca-11,13-dienoic acid Chemical compound CCCCC=CC=CCCCCCCCCCC(O)=O JGFMXQLVWUGIPI-UHFFFAOYSA-N 0.000 description 1
- PJSQIDIRJGWHOB-UHFFFAOYSA-N octadeca-4,6-dienoic acid Chemical compound CCCCCCCCCCCC=CC=CCCC(O)=O PJSQIDIRJGWHOB-UHFFFAOYSA-N 0.000 description 1
- CNKMVAJDUBKHMS-UHFFFAOYSA-N octadeca-6,8-dienoic acid Chemical compound CCCCCCCCCC=CC=CCCCCC(O)=O CNKMVAJDUBKHMS-UHFFFAOYSA-N 0.000 description 1
- HACBQSMIIGXKGA-UHFFFAOYSA-N octadeca-7,9-dienoic acid Chemical compound CCCCCCCCC=CC=CCCCCCC(O)=O HACBQSMIIGXKGA-UHFFFAOYSA-N 0.000 description 1
- QJKCKUNKNNYJNS-UHFFFAOYSA-N octadeca-8,10-dienoic acid Chemical compound CCCCCCCC=CC=CCCCCCCC(O)=O QJKCKUNKNNYJNS-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 235000018770 reduced food intake Nutrition 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 102220240796 rs553605556 Human genes 0.000 description 1
- 102220229106 rs753340463 Human genes 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
- C11C1/025—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by saponification and release of fatty acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/02—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/14—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by isomerisation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Husbandry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/072,421 US6214372B1 (en) | 1998-05-04 | 1998-05-04 | Method of using isomer enriched conjugated linoleic acid compositions |
| US09/072,421 | 1998-05-04 | ||
| US09/072,422 US6060514A (en) | 1998-05-04 | 1998-05-04 | Isomer enriched conjugated linoleic acid compositions |
| US09/072,422 | 1998-05-04 | ||
| PCT/US1999/005807 WO1999056780A1 (en) | 1998-05-04 | 1999-03-17 | Isomer enriched conjugated linoleic acid compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002188786A Division JP2003047439A (ja) | 1998-05-04 | 2002-06-27 | 異性体濃縮共役リノール酸組成物の使用方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001508812A true JP2001508812A (ja) | 2001-07-03 |
Family
ID=26753359
Family Applications (12)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55536299A Withdrawn JP2001508812A (ja) | 1998-05-04 | 1999-03-17 | 異性体濃縮共役リノール酸組成物 |
| JP55536399A Pending JP2001508085A (ja) | 1998-05-04 | 1999-03-17 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2001383829A Pending JP2002223722A (ja) | 1998-05-04 | 2001-12-17 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2002188786A Pending JP2003047439A (ja) | 1998-05-04 | 2002-06-27 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2002188788A Pending JP2003113080A (ja) | 1998-05-04 | 2002-06-27 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2003130313A Pending JP2003319759A (ja) | 1998-05-04 | 2003-05-08 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2010119795A Withdrawn JP2010195825A (ja) | 1998-05-04 | 2010-05-25 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2010119924A Withdrawn JP2010259437A (ja) | 1998-05-04 | 2010-05-25 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2013025421A Withdrawn JP2013106613A (ja) | 1998-05-04 | 2013-02-13 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2013054623A Withdrawn JP2013165717A (ja) | 1998-05-04 | 2013-03-18 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2014187525A Pending JP2015037410A (ja) | 1998-05-04 | 2014-09-16 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2014187486A Pending JP2015044810A (ja) | 1998-05-04 | 2014-09-16 | 異性体濃縮共役リノール酸組成物の使用方法 |
Family Applications After (11)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55536399A Pending JP2001508085A (ja) | 1998-05-04 | 1999-03-17 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2001383829A Pending JP2002223722A (ja) | 1998-05-04 | 2001-12-17 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2002188786A Pending JP2003047439A (ja) | 1998-05-04 | 2002-06-27 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2002188788A Pending JP2003113080A (ja) | 1998-05-04 | 2002-06-27 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2003130313A Pending JP2003319759A (ja) | 1998-05-04 | 2003-05-08 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2010119795A Withdrawn JP2010195825A (ja) | 1998-05-04 | 2010-05-25 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2010119924A Withdrawn JP2010259437A (ja) | 1998-05-04 | 2010-05-25 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2013025421A Withdrawn JP2013106613A (ja) | 1998-05-04 | 2013-02-13 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2013054623A Withdrawn JP2013165717A (ja) | 1998-05-04 | 2013-03-18 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2014187525A Pending JP2015037410A (ja) | 1998-05-04 | 2014-09-16 | 異性体濃縮共役リノール酸組成物の使用方法 |
| JP2014187486A Pending JP2015044810A (ja) | 1998-05-04 | 2014-09-16 | 異性体濃縮共役リノール酸組成物の使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6225486B1 (enExample) |
| EP (2) | EP0954983B1 (enExample) |
| JP (12) | JP2001508812A (enExample) |
| KR (2) | KR100402040B1 (enExample) |
| AT (2) | ATE313274T1 (enExample) |
| AU (2) | AU747057B2 (enExample) |
| CA (2) | CA2293336C (enExample) |
| DE (2) | DE69936484T2 (enExample) |
| DK (2) | DK0954983T3 (enExample) |
| ES (2) | ES2286867T3 (enExample) |
| IN (1) | IN214289B (enExample) |
| MX (2) | MX234917B (enExample) |
| NO (2) | NO332473B1 (enExample) |
| WO (2) | WO1999056780A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539807A (ja) * | 1999-03-30 | 2002-11-26 | ウイスコンシン アラムナイ リサーチ フオンデーシヨン | 体脂肪レベル、飼料効率、または体重増加を選択的に変化させる方法 |
| JP2006517237A (ja) * | 2002-09-24 | 2006-07-20 | ナチュラル エイエスエイ | 共役リノール酸組成物 |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101914B2 (en) * | 1998-05-04 | 2006-09-05 | Natural Asa | Isomer enriched conjugated linoleic acid compositions |
| FR2784268B1 (fr) * | 1998-10-12 | 2000-12-29 | Gervais Danone Sa | Nouvelle composition alimentaire, a base de matiere issue du lait, sous la forme d'une emulsion huile dans eau |
| GB9828380D0 (en) * | 1998-12-22 | 1999-02-17 | Unilever Plc | Skin lightening composition |
| JP4565750B2 (ja) * | 1999-04-27 | 2010-10-20 | 株式会社ヤクルト本社 | 共役リノール酸エステルの製造法 |
| JP3207823B2 (ja) | 1999-04-28 | 2001-09-10 | リノール油脂株式会社 | 共役リノール酸を有効成分とする褐色脂肪増加剤 |
| US6420577B1 (en) * | 1999-12-01 | 2002-07-16 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture | Method for commercial preparation of conjugated linoleic acid |
| JP4262382B2 (ja) * | 2000-02-03 | 2009-05-13 | 株式会社ヤクルト本社 | 共役脂肪酸グリセリド含有発酵食品及びその製造法 |
| WO2001060331A2 (en) * | 2000-02-15 | 2001-08-23 | Zen-Bio, Inc. | Compositions for preventing cellulite in mammalian skin |
| CA2404799C (en) * | 2000-04-06 | 2007-08-07 | Conlinco, Inc. | Conjugated linoleic acid compositions |
| US20030149288A1 (en) * | 2000-04-18 | 2003-08-07 | Natural Asa | Conjugated linoleic acid powder |
| JP5258134B2 (ja) * | 2000-04-18 | 2013-08-07 | エイカー バイオマリン アーエスアー | 共役リノール酸粉末 |
| US6380409B1 (en) * | 2000-04-24 | 2002-04-30 | Conlin Co., Inc. | Methods for preparing CLA isomers |
| US7025984B1 (en) * | 2000-06-26 | 2006-04-11 | The Procter & Gamble Company | Compositions and methods for body weight management |
| AU2005242170B2 (en) * | 2000-06-26 | 2008-12-18 | The Procter & Gamble Company | Compositions and methods for body weight management |
| US6809115B2 (en) * | 2000-09-21 | 2004-10-26 | Nutrition 21, Inc. | Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| WO2002041706A2 (en) * | 2000-11-21 | 2002-05-30 | Alpha Foods Ingredients, Inc. | Bioactive compositions comprising conjugated linoleic acid glycerides and methods for producing bioactive conjugated linoleic acid |
| GB0105622D0 (en) | 2001-03-07 | 2001-04-25 | Natural Asa | Compositions |
| CA2442106A1 (en) * | 2001-03-29 | 2002-10-10 | Basf Aktiengesellschaft | Conjugated unsaturated glyceride mixtures and a method for producing the same |
| KR20020081632A (ko) * | 2001-04-19 | 2002-10-30 | (주)라이브맥스 | Ｃｌａ가 함유된 재구성 지질의 제조방법 및 이용방법 |
| US6677470B2 (en) | 2001-11-20 | 2004-01-13 | Natural Asa | Functional acylglycerides |
| DE10158046A1 (de) * | 2001-11-27 | 2003-06-05 | Basf Ag | Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung |
| WO2003061402A2 (en) * | 2002-01-22 | 2003-07-31 | Mars, Incorporated | Reduction of renal damage in companion animals |
| US20030138547A1 (en) * | 2002-01-22 | 2003-07-24 | Mars, Incorporated | Weight management system for animals |
| DE10219781A1 (de) | 2002-05-03 | 2003-11-13 | Cognis Deutschland Gmbh | Verfahren zur Herstellung von konjugierten Linolsäureglyceriden |
| DE10236086A1 (de) * | 2002-08-07 | 2004-02-19 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung von konjugierter Linolsäure |
| US20040044079A1 (en) * | 2002-09-04 | 2004-03-04 | The Iams Company | Methods and compositions for weight control |
| US7244874B2 (en) * | 2002-09-17 | 2007-07-17 | The Regents Of The University Of California | Stearoyl CoA desaturase transgenic non-human animals |
| WO2004048504A2 (en) * | 2002-11-26 | 2004-06-10 | George Washington University | Method and composition with conjugated linoleic acid esters |
| JP4510045B2 (ja) * | 2003-01-31 | 2010-07-21 | 日清オイリオグループ株式会社 | 共役リノール酸異性体の精製方法およびその用途 |
| JP2004248671A (ja) * | 2003-01-31 | 2004-09-09 | Rinoru Oil Mills Co Ltd | 共役リノール酸異性体の精製方法およびその用途 |
| WO2004096748A1 (en) * | 2003-04-25 | 2004-11-11 | Ilshinwells Co., Ltd. | Preparation method of conjugated linoleic acid diglycerides |
| US6897327B2 (en) * | 2003-05-08 | 2005-05-24 | Stepan Company | Manufacture of conjugated linoleic salts and acids |
| US20040228948A1 (en) * | 2003-05-16 | 2004-11-18 | Kennelly John J. | Increasing the concentration of conjugated linoleic acid isomers in the milk fat and/or tissue fat of ruminants |
| US20050069593A1 (en) * | 2003-09-29 | 2005-03-31 | Life Time Fitness, Inc. | Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid |
| EP1541040A1 (de) * | 2003-12-04 | 2005-06-15 | Cognis Iberia S.L | Zubereitung zur oralen Aufnahme (VI) enthaltend einen Extrakt oder Wirkstoffe der Pflanze Medicago sativa |
| AU2003299920A1 (en) * | 2003-12-23 | 2005-08-03 | Stepan Company | Production and purification of esters of conjugated linoleic acids |
| US20050215641A1 (en) * | 2004-03-10 | 2005-09-29 | Asgeir Saebo | Compositions comprising reverse isomers of conjugated linoleic acid |
| US7767713B2 (en) * | 2004-08-05 | 2010-08-03 | Palo Alto Investors | Linoleic acid active agents for enhancing probability of becoming pregnant |
| EP1627565A1 (en) * | 2004-08-10 | 2006-02-22 | Consejo Superior de Investigaciones Cientificas (CSIC) | Use of flavanol derivatives for the cryopreservation of living cells |
| ES2258928A1 (es) * | 2005-02-25 | 2006-09-01 | Aceites Borges Pont, S.A. | Composicion a base de aceites vegetales y acido linoleico conjugado. |
| DE602006016476D1 (de) * | 2005-12-05 | 2010-10-07 | Stepan Co | Verfahren zur herstellung von konjugierter linolsäure und derivaten davon aus ricinolsäure |
| WO2007118614A1 (en) * | 2006-04-13 | 2007-10-25 | Lipid Nutrition B.V. | Process for producing isomer enriched conjugated linoleic acid compositions |
| JP5099808B2 (ja) * | 2006-05-29 | 2012-12-19 | 独立行政法人農業・食品産業技術総合研究機構 | 脂質代謝改善用組成物 |
| DE102007009649A1 (de) * | 2007-02-26 | 2008-08-28 | Beiersdorf Ag | Nahrungsergänzungsmittel zur Pflege und/oder Verschönerung der Haut |
| JP2008237032A (ja) * | 2007-03-23 | 2008-10-09 | Ezaki Glico Co Ltd | 高嗜好性食品 |
| CN101686696A (zh) * | 2007-04-24 | 2010-03-31 | 脂质营养品有限公司 | 低糖酸奶 |
| KR100809411B1 (ko) * | 2007-08-31 | 2008-03-05 | (주)에이치케이바이오텍 | 체지방감소용 조성물 |
| ES2430200T3 (es) * | 2007-10-29 | 2013-11-19 | Stepan Specialty Products, Llc | Composición de aderezo |
| KR101482775B1 (ko) * | 2010-08-25 | 2015-01-16 | 이화여자대학교 산학협력단 | 운데실렌산 및/또는 공액리놀렌산을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
| WO2012026663A1 (ko) * | 2010-08-25 | 2012-03-01 | 이화여자대학교 산학협력단 | 운데실렌산, 공액리놀레산 및/또는 공액리놀레산 이성질체를 포함하는 항암보조제 |
| AU2014228387B2 (en) | 2013-03-11 | 2016-09-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
| CN120240575A (zh) * | 2014-03-13 | 2025-07-04 | 巴斯夫欧洲公司 | 富含瘤胃不稳定成分的颗粒的反刍动物饲料 |
| KR101907438B1 (ko) * | 2016-12-08 | 2018-10-15 | 현대오트론 주식회사 | 차량용 게이트웨이의 주기 메시지 송수신 방법 |
| CN112451512A (zh) * | 2020-11-26 | 2021-03-09 | 青海省人民医院 | 一种药物组合物及其治疗骨质疏松的用途 |
| CN116618414A (zh) * | 2023-05-25 | 2023-08-22 | 贵州民族大学 | 一种餐厨垃圾全量资源化利用方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3729379A (en) | 1971-08-31 | 1973-04-24 | Us Agriculture | Hydroxy-conjugated fatty acids |
| US4164505A (en) | 1977-07-08 | 1979-08-14 | Sylvachem Corporation | Flow process for conjugating unconjugated unsaturation of fatty acids |
| US5208356A (en) | 1989-02-17 | 1993-05-04 | Wisconsin Alumni Research Foundation | Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions |
| GB2240051B (en) | 1990-01-18 | 1993-04-14 | Pall Corp | Cylindrical filters and their manufacture |
| US5674901A (en) | 1995-06-01 | 1997-10-07 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations |
| US5428072A (en) * | 1992-04-29 | 1995-06-27 | Wisconsin Alumni Research Foundation | Method of increasing the efficiency of feed conversion in animals |
| US5554646A (en) * | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
| US5430066A (en) | 1992-04-29 | 1995-07-04 | Wisconsin Alumni Research Foundation | Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation |
| US5814663A (en) | 1994-08-29 | 1998-09-29 | Wisconsin Alumni Research Foundation | Method for maintaining an existing level of body fat |
| US5760082C1 (en) | 1994-08-29 | 2001-03-06 | Wisconsin Alumni Res Found | Dietetic foods containing conjugated linoleic acids |
| US5856149A (en) | 1995-06-01 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method of producing conjugated fatty acids |
| DE69615513T2 (de) | 1995-11-14 | 2002-05-08 | Unilever N.V., Rotterdam | Essbarer Brotaufstrich |
| KR100300826B1 (ko) * | 1995-11-14 | 2001-08-31 | 씨.지. 온닝크 | 장쇄다불포화지방산을다량함유한물질의제조방법 |
| US5585400A (en) | 1996-02-27 | 1996-12-17 | Wisconsin Alumni Research Foundation | Methods of attenuating the allergic response in animals |
| US5804210A (en) | 1996-08-07 | 1998-09-08 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein |
| US5760083A (en) | 1996-08-07 | 1998-06-02 | Wisconsin Alumni Research Foundation | Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry |
| JP3017108B2 (ja) | 1996-10-30 | 2000-03-06 | リノール油脂株式会社 | 共役リノール酸の製造方法 |
| US5855917A (en) | 1996-12-04 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids |
| US5851572A (en) | 1997-04-25 | 1998-12-22 | Wisconsin Alumni Research Foundation | Method of increasing fat firmness and improving meat quality in animals with conjugated linolenic acid |
| DE19718245C5 (de) | 1997-04-30 | 2004-11-11 | Cognis Deutschland Gmbh & Co. Kg | Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung |
| SE9704584L (sv) * | 1997-12-05 | 1999-07-19 | Lennart Bjoerck | Framställning av konjugerad linolsyra |
| US6015833A (en) | 1998-03-17 | 2000-01-18 | Conlinco., Inc. | Conjugated linoleic acid compositions |
-
1999
- 1999-03-17 WO PCT/US1999/005807 patent/WO1999056780A1/en not_active Ceased
- 1999-03-17 MX MXPA00010794 patent/MX234917B/es active IP Right Grant
- 1999-03-17 MX MXPA00010793 patent/MX228618B/es active IP Right Grant
- 1999-03-17 JP JP55536299A patent/JP2001508812A/ja not_active Withdrawn
- 1999-03-17 DK DK99105495T patent/DK0954983T3/da active
- 1999-03-17 JP JP55536399A patent/JP2001508085A/ja active Pending
- 1999-03-17 DK DK99105496T patent/DK0954975T3/da active
- 1999-03-17 CA CA002293336A patent/CA2293336C/en not_active Expired - Fee Related
- 1999-03-17 EP EP99105495A patent/EP0954983B1/en not_active Expired - Lifetime
- 1999-03-17 IN IN487KO2000 patent/IN214289B/en unknown
- 1999-03-17 ES ES99105495T patent/ES2286867T3/es not_active Expired - Lifetime
- 1999-03-17 AT AT99105496T patent/ATE313274T1/de not_active IP Right Cessation
- 1999-03-17 DE DE69936484T patent/DE69936484T2/de not_active Expired - Lifetime
- 1999-03-17 AT AT99105495T patent/ATE366521T1/de not_active IP Right Cessation
- 1999-03-17 AU AU30083/99A patent/AU747057B2/en not_active Ceased
- 1999-03-17 EP EP99105496A patent/EP0954975B1/en not_active Expired - Lifetime
- 1999-03-17 KR KR20007012218A patent/KR100402040B1/ko not_active Expired - Fee Related
- 1999-03-17 ES ES99105496T patent/ES2255741T3/es not_active Expired - Lifetime
- 1999-03-17 WO PCT/US1999/005808 patent/WO1999056781A1/en not_active Ceased
- 1999-03-17 CA CA002293338A patent/CA2293338C/en not_active Expired - Fee Related
- 1999-03-17 DE DE69928986T patent/DE69928986T2/de not_active Expired - Lifetime
- 1999-03-17 KR KR1020007012280A patent/KR100655838B1/ko not_active Expired - Fee Related
- 1999-03-17 US US09/270,941 patent/US6225486B1/en not_active Expired - Lifetime
- 1999-03-17 AU AU30953/99A patent/AU747058B2/en not_active Ceased
-
2000
- 2000-11-03 NO NO20005565A patent/NO332473B1/no not_active IP Right Cessation
- 2000-11-03 NO NO20005566A patent/NO332474B1/no not_active IP Right Cessation
-
2001
- 2001-01-30 US US09/772,608 patent/US6333353B2/en not_active Expired - Lifetime
- 2001-12-17 JP JP2001383829A patent/JP2002223722A/ja active Pending
-
2002
- 2002-06-27 JP JP2002188786A patent/JP2003047439A/ja active Pending
- 2002-06-27 JP JP2002188788A patent/JP2003113080A/ja active Pending
-
2003
- 2003-05-08 JP JP2003130313A patent/JP2003319759A/ja active Pending
-
2010
- 2010-05-25 JP JP2010119795A patent/JP2010195825A/ja not_active Withdrawn
- 2010-05-25 JP JP2010119924A patent/JP2010259437A/ja not_active Withdrawn
-
2013
- 2013-02-13 JP JP2013025421A patent/JP2013106613A/ja not_active Withdrawn
- 2013-03-18 JP JP2013054623A patent/JP2013165717A/ja not_active Withdrawn
-
2014
- 2014-09-16 JP JP2014187525A patent/JP2015037410A/ja active Pending
- 2014-09-16 JP JP2014187486A patent/JP2015044810A/ja active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539807A (ja) * | 1999-03-30 | 2002-11-26 | ウイスコンシン アラムナイ リサーチ フオンデーシヨン | 体脂肪レベル、飼料効率、または体重増加を選択的に変化させる方法 |
| JP2006517237A (ja) * | 2002-09-24 | 2006-07-20 | ナチュラル エイエスエイ | 共役リノール酸組成物 |
| JP2011190451A (ja) * | 2002-09-24 | 2011-09-29 | Aker Biomarine Asa | 共役リノール酸組成物 |
| JP2014159580A (ja) * | 2002-09-24 | 2014-09-04 | Aker Biomarine Asa | 共役リノール酸組成物 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001508812A (ja) | 異性体濃縮共役リノール酸組成物 | |
| US7094420B2 (en) | Methods of using isomer enriched conjugated linoleic acid compositions | |
| US6242621B1 (en) | Isomer enriched conjugated linoleic acid compositions | |
| AU2001257627A1 (en) | Methods for preparing CLA isomers | |
| EP1276709A2 (en) | Methods for preparing cla isomers | |
| US7101914B2 (en) | Isomer enriched conjugated linoleic acid compositions | |
| US6696584B2 (en) | Isomer enriched conjugated linoleic acid compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20041108 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20041118 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050210 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060206 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060210 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20061228 |